We would like to express our appreciation to the authors of the letter to the editor
for their interest in our recent article.
1
They argued that the control group in our study should be considered a very low dose
extracorporeal shockwave therapy (ESWT) group rather than a placebo. We see their
comments as an opportunity to provide more insight into designing a placebo in the
ESWT study. The following is our explanation of the control group as a placebo group
in our trial.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Archives of Physical Medicine and RehabilitationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A randomized controlled trial on the effects of low-dose extracorporeal shockwave therapy in patients with knee osteoarthritis.Arch Phys Med Rehabil. 2019; 100: 1695-1702
- Repetitive low-energy shock wave treatment for chronic lateral epicondylitis in tennis players.Am J Sports Med. 2004; 32: 734-743
- Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial.JAMA. 2003; 290: 2573-2580
- Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis: a randomized controlled trial.JAMA. 2002; 288: 1364-1372
- Efficacy of radial extracorporeal shock wave therapy on lateral epicondylosis, and changes in the common extensor tendon stiffness with pretherapy and posttherapy in real-time sonoelastography: a arandomized controlled study.Am J Phys Med Rehabil. 2017; 96: 93-100
Article info
Publication history
Published online: May 10, 2020
Footnotes
Disclosures: none.
Identification
Copyright
© 2020 by the American Congress of Rehabilitation Medicine
ScienceDirect
Access this article on ScienceDirectLinked Article
- Extracorporeal Shockwave Therapy and Knee Osteoarthritis: Defining a Placebo GroupArchives of Physical Medicine and RehabilitationVol. 101Issue 7
- PreviewIn the recently published study by Zhong et al, “A Randomized Controlled Trial on the Effects of Low-Dose Extracorporeal Shockwave Therapy in Patients With Knee Osteoarthritis,” the researchers studied low-dose extracorporeal shockwave therapy (ESWT) treatment in patients with knee osteoarthritis. They stated that ESWT was superior to placebo in both pain and functional improvement, as well as in terms of negative effects on the articular cartilage.
- Full-Text
- Preview
